ProZyme
Hayward
About ProZyme
ProZyme, Inc., established in 1990, specializes in the development of value-added reagents, kits and platforms for improved analytical results. Technologies used includes: microbial fermentation sciences; large-scale native and recombinant purification and formulation; assay development and analytical services for our customers. Analytical methods employed include HPLC, CE, bead-based immunassays and ELISAs. Most recently ProZyme has commercialized the GlykoPrep™ Sample Preparation Platform to significantly speed and simplify sample preparation for glycoanalysis, yielding high-quality results to support all stages of biopharmaceutical drug development and manufacture.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $321.4K
- Funding stage: M&A
- Last round: Debt Financing (Oct 2011)
- Website: prozyme.com
- Phone: 510-638-6900
Industries & Categories
Biotechnology, Health Diagnostics, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/prozyme-3451460 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.